Pyrimidodiazepine, a ring-strained cofactor for phenylalanine hydroxylase.

Area of Science:

• Biochemistry
• Organic Chemistry
• Enzymology

Background:

• Pteridine derivatives are crucial cofactors in various biological redox reactions.
• Understanding the structure-activity relationship of pteridine analogues aids in elucidating enzymatic mechanisms.
• The pyrimidodiazepine series represents a class of pteridine analogues with potential biological relevance.

Purpose of the Study:

• To synthesize pyrimidodiazepine analogues with expanded pyrazine rings.
• To investigate the impact of increased ring strain on the chemical and enzymatic properties of these analogues.
• To compare the behavior of pyrimidodiazepine analogues with their pteridine counterparts.

Main Methods:

• Chemical synthesis of 6-methyl-7,8-dihydropyrimidodiazepine (6-Me-7,8-PDH2) and its tetrahydro form (6-Me-PDH4).
• Assessment of chemical stability in neutral solutions and susceptibility to hydrolysis and autooxidation.
• Enzymatic reduction of 6-Me-7,8-PDH2 using dihydrofolate reductase and oxidation of 6-Me-PDH4 using halogen.
• Enzymatic assays with phenylalanine hydroxylase and dihydropteridine reductase.
• Analysis of tautomerization and decomposition pathways of quinoid forms.

Main Results:

• 6-Me-7,8-PDH2 exhibited lower stability than its pteridine analogue (6-Me-7,8-PH2), decomposing via hydrolytic ring opening and autooxidation.
• 6-Me-7,8-PDH2 was reduced to 6-Me-PDH4 and oxidized to quinoid 6-Me-PDH2, a substrate for dihydropteridine reductase.
• Quinoid 6-Me-PDH2 showed increased decomposition compared to quinoid 6-methyldihydropterin, indicating higher strain in the pyrimidodiazepine system.
• Phenylalanine hydroxylase utilized 6-Me-PDH4, but tyrosine production was significantly slower than with 6-Me-PH4, suggesting ring opening is not rate-limiting.
• Variations in maximum velocities for different pyrimidinone cofactors suggest oxygen transfer is not the rate-limiting step in phenylalanine hydroxylation.

Conclusions:

• The expanded pyrazine ring in pyrimidodiazepines introduces significant strain, altering chemical stability and enzymatic interactions.
• The observed differences in stability and reactivity highlight the importance of ring structure in pteridine cofactor function.
• The study provides evidence that ring opening is not the rate-limiting step in phenylalanine hydroxylation by phenylalanine hydroxylase.